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Abstract
Background
Invasive meningococcal disease (IMD) is a highly lethal disease. Diagnosis is commonly
performed by culture or Realtime-PCR (qPCR).
Aims
Our aim was to evaluate, retrospectively, whether culture positivity correlates with higher
bacterial load and fatal outcome. Our secondary aim was to compare culture and qPCR
sensitivity.
Methods
The National Register for Molecular Surveillance was used as data source. Cycle threshold
(CT), known to be inversely correlated with bacterial load, was used to compare bacterial
load in different samples.
Results
Three-hundred-thirteen patients were found positive for Neisseria meningitidis by qPCR, or
culture, or both; 41 died (case fatality rate 13.1%); 128/143 (89.5%) blood samples and
138/144 (95.8%) CSF were positive by qPCR, 37/143 (25.9%) blood samples and 45/144
(31.2%) CSF were also positive in culture. qPCR was 3.5 times (blood) or 3.1 times (CSF)
more sensitive than culture in achieving a laboratory diagnosis of IMD (OR 24.4; 95% CI
12.2–49.8; p < .10−4; Cohen’s κ 0.08 for blood and OR 49.0; 95% CI 19.1–133.4; p<10−4;
Cohen’s κ 0.02; for CSF). Positivity of culture did not correlate with higher bacterial loads in
blood (mean CT 27.7±5.71, and CT 28.1±6.03, p = 0.739 respectively in culture positive or
negative samples) or in CSF (mean CT 23.1±4.9 and 24.7±5.4 respectively in positive or
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negative CSF samples, p = 0.11).CT values in blood from patients who died were signifi-
cantly lower than in patients who survived (respectively mean 18.0, range 14–23 and mean
29.6, range 16–39; p<10−17). No deaths occurred in patients with CT in blood over 23. Posi-
tive blood cultures were found in 10/25 (40%) patients who died and in 32/163 (19.6%)
patients who survived, p = 0.036, OR 2.73; 95% CL 1.025–7.215), however 60% of deaths
would have remained undiagnosed with the use of culture only.
Conclusions
In conclusion our study demonstrated that qPCR is significantly (at least 3 times) more sen-
sitive than culture in the laboratory confirmation of IMD. The study also demonstrated that
culture negativity is not associated with lower bacterial loads and with less severe cases. On
the other side, in patients with sepsis, qPCR can predict fatal outcome since higher bacterial
load, evaluated by qPCR, appears strictly associated with most severe cases and fatal out-
come. The study also showed that molecular techniques such as qPCR can provide a valu-
able addition to the proportion of diagnosed and serotyped cases of IMD.
Introduction
Neisseria meningitidis is a major etiologic agent of bacterial meningitis and one of the most
important causes of sepsis, meningitis and other invasive bacterial diseases [1–2]. Invasive
meningococcal disease (IMD) is a serious infectious disease with high morbidity and mortality
rates. Diagnosis is commonly performed by culture methods or by the Real-time Polymerase
Chain Reaction (qPCR).
Studies performed in different countries demonstrated that qPCR is significantly more sen-
sitive than culture in the diagnosis of IMD [3–6]. In England 54–57% of cases were confirmed
by qPCR only [3–4], in Italy that percentage is 58% [5], in Greece, in a study comparing cul-
ture and qPCR in the ability to detect pathogens causing meningitis, over 75% of cases were
detected only by PCR [7]. Similar results were obtained in Delhi, India [8] where qPCR
allowed serotyping of large numbers of culture negative samples so that authors concluded
that molecular techniques are “of paramount importance in epidemiological surveillance espe-
cially in developing countries like India”.
However, at present it is not known whether cases lost to diagnosis in settings where only
cultural tests are routinely performed are the least severe ones and/or those associated with
atypical presentation.
Compared to qPCR, culture needs larger volume of sample in order to get an optimal bacte-
rial yield and obtain bacterial growth [9] and it might be hypothesized that samples with higher
bacterial load have the highest probability to be found positive in culture. Since high bacterial
load is usually associated with more severe cases and poorer outcome, it could be inferred that
culture can identify the most severe cases. However occasional observations in our previous
studies [5–6] conflicted with that hypothesis.
Real-time PCR can give both quantitative and semi-quantitative results [10–11]. The cycle
threshold (CT) value is the qPCR cycle number (of 40) at which the measured fluorescent sig-
nal exceeds a calculated background threshold, identifying amplification of the target
sequence. Cycle threshold is inversely correlated with bacterial loads and it is commonly used
as a proxy of bacterial load. CT can therefore be used to compare bacterial loads in different
Real-time Polymerase Chain Reaction and culture in the diagnosis of invasive meningococcal disease
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samples and as an indicator of disease severity both in IMD and in other bacterial diseases
[12–16].
Therefore the first aim of the present work was to evaluate whether culture positivity corre-
lates with higher bacterial loads measured by qPCR and/or with greater disease severity leading
to a fatal outcome. Our second aim was to compare qPCR and culture sensitivity in the diag-
nosis of IMD in a pediatric hospital setting.
Patients and methods
Study design and case definition
This study evaluated retrospectively all patients with IMD caused by Neisseria meningitidis
(sepsis or meningitis) included in the molecular surveillance register from 2007 to 2016. The
register was started in 2006 in the Immunology and Infectious Disease Laboratory of the
Meyer Children’s University Hospital (Florence, Italy) and was subsequently expanded with
dedicated funds from the Italian Center for Disease Control (CCM) aimed to improve molecu-
lar diagnosis of invasive bacterial infections. The register was initially focused on pediatric
cases: pediatric hospitals in Italy were invited to participate. Upon request by clinicians, sam-
ples obtained from adults were accepted and tested with real time PCR (qPCR) and included
in the register. The number of adult patients increased over the years. Molecular surveillance
was organized and is still active as a voluntary surveillance. All samples submitted to Meyer
University Hospital (blood, cerebrospinal fluid, post mortem samples or other normally sterile
fluids), were accompanied by clinical, demographic and outcome (death versus survival) data
on the patients. The study was approved by the review board of the Department of Health Sci-
ences. All samples included in this study had been collected as part of the routine clinical activ-
ity, and were analyzed anonymously. For that reason, a specific approval by the local ethics
committee (Tuscany Regional Pediatric Ethical Committee) was not required.
The reporting of a culture-based test was welcome but not required for a case to be included
in the register, so the results of culture tests were not available for all patients. Samples for
molecular tests were sent to Meyer Children’s University Hospital by using a fast freepost car-
rier. Within 2 hours of delivery, 200 μL of sample were used for molecular diagnosis and sero-
typing by qPCR. Culture tests were performed by local laboratories at the original hospitals,
following the hospitals’ own procedures.
Meningitis was clinically suspected in the presence of previously described signs [17]. Sepsis
was clinically suspected in the presence of a compatible clinical syndrome and abnormal
chemical test results [18]. A case was considered confirmed in the presence of positive culture
or molecular tests [5].
Diagnostic criteria
Laboratory confirmed diagnosis of IMD was made in the presence of qPCR positive for ctrA
gene, or culture positivity for Neisseria meningitidis or both, as previously described [6]. Quan-
tification of the N. meningitidis bacterial load was performed using the capsular transfer gene
(ctrA), which has been shown to be specific for N. meningitidis. CtrA is a single-copy gene, the
number of copies measured is equivalent to the bacterial load number in a range of 103−109
copies/mL [14]. The CT is the value at which a fluorescent signal exceeds the background indi-
cating amplification. If there was no increase in fluorescent signal before the 40th cycle, the
sample was assumed to be negative.
Meningococcal serogrouping was performed by qPCR according to previously published
procedures [6] and according CDC procedures (http://www.cdc.gov/meningitis/lab-manual/
chpt10-pcr.html).
Real-time Polymerase Chain Reaction and culture in the diagnosis of invasive meningococcal disease
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Statistical analysis
Data was processed with SPSSX v.15.0: p<0.05 was considered to be statistically significant.
The χ2 test or Fisher test was used to assess group differences in categorical variables. Odd
ratios and 95%
confidence intervals (CIs) were calculated when possible. For continuous variables, Stu-
dent’s test was used. Cohen’s κ and McNemar’s tests were also used for comparison of
sensitivity.
The STARD 2015 (updated list of essential items for reporting diagnostic accuracy studies;
http://www.equator-network.org/reporting-guidelines/stard/) has been followed.
Results
One-hundred and eighteen hospital from 18/20 Italian Regions participated in the molecular
surveillance project (S1 and S2 Figs). The two regions that did not participate in the surveil-
lance represent, together, 0.7% of the Italian population. Patients with invasive meningococcal
infections were recruited from 85 hospitals. Clinical and demographic data are shown in
Table 1.
Since the absence of data regarding culture-based test report was not an exclusion criterion
for a case to be included in the molecular surveillance register, data on culture-based tests were
not available for all patients; in details: data were available for 188 of the 199 blood samples
and for 146 of the 221 CSF samples.
Table 1. Clinical and demographic data of patients included in the study.
Number of patients 313
Number of samples Blood samples 221
Cerebrospinal fluid samples 3
Post-mortem specimens 2
Synovial fluid 199
Sex Males 161 (51.4%)
Females 152 (48.5%)
Age range (years) 0.1–89.3
Distribution of patients in age classes 0–5 years 25 (8.0%)
5–10 years 50 (16.0%)
11–20 years 119 (38.0%)
>20 years 119 (38.0%)
Distribution of patients according to clinical presentation at
hospital admission
Sepsis 35 (11.2%)
Sepsis and meningitis 183 (58.5%)
Meningitis with no mention of
sepsis
3 (1.0%)
Arthritis 2 (0.6%)
Pneumonia 2 (0.6%)
Unknown 88 (28.1%)
Antibiotic treatment before microbiological tests Yes 170 (54.3%)
No 9 (2.9%)
Unknown 134
(42.8%)�
�84/134 (62.7%) had received the first dose of antibiotic just before sample was taken
https://doi.org/10.1371/journal.pone.0212922.t001
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All 313 patients were found positive for Neisseria meningitidis by qPCR or culture or both.
In particular, all of them were found positive by qPCR (in CSF or blood or other normally ster-
ile fluids or in more than one sample): 181/199 (91.0%) were positive in blood, 215/221
(97.3%) were positive in CSF, and 5 were positive in other materials (3/5 taken post-mortem);
42/188 (22.3%) blood cultures and 46/147 (31.3%) CSF cultures were positive.
qPCR allowed serogrouping in 307/313 patients; 6 patients were not serogrouped for sam-
ple scarcity. Serogroup distribution was the following: 189/307 serogroup B (61.6%), 95/307
serogroup C (30.9%), 12/307 serogroup W (3.9%), 11 serogroup Y (3.6%).
Sensitivity of qPCR versus culture in blood or CSF
In order to compare sensitivity of qPCR and cultures, we included in the analysis all the sam-
ples that had been drawn at the same time to be tested for both qPCR and culture.
One hundred and forty-three blood samples were available for the study. Among them 128/
143 (89.5%) were positive by qPCR and 37/143 (25.9%) were positive by culture. All the 15
cases that were negative by qPCR in blood had been admitted to hospital with the clinical sus-
picion of meningitis only, with no mention of sepsis, and all of them were found positive in
CSF by qPCR. Details are shown in Table 2.
On blood samples, qPCR was 3.5 times more sensitive than culture and qPCR was signifi-
cantly more sensitive than culture in achieving laboratory diagnosis of IMD (Odds ratio 24.4;
95% CI 12.2–49.8; p< .10−4 by χ2 test; Cohen’s κ 0.08; p<10−4 by McNemar’s test).
As for CSF, 144 samples, taken simultaneously for both qPCR and culture, were available.
Among them 138/144 (95.8%) were positive by qPCR and 46/144 (31.9%) were positive by
culture. Details are shown in Table 2. On CSF samples, qPCR was 3.1 times more sensitive
than CSF culture and was significantly more sensitive than culture in achieving laboratory
diagnosis of IMD (Odds ratio 49.0; 95% CI 19.1–133.4; p<10−4 by χ2 test; Cohen’s κ 0.02;
p<10−4 by McNemar’s test).
Culture positivity rate was not different in different ages or in different Italian regions.
Correlation between bacterial load in blood and positivity of blood cultures
In order to evaluate whether culture positivity correlates with higher bacterial loads, we
included in that analysis all the samples that were positive in blood with qPCR and for which
culture tests had been performed (n = 128). Blood culture was positive in 37/128 (28.9%) while
blood samples were negative in culture in 90/128 (70.3%) and one sample (0.78%) was
reported as contaminated by Streptococcus viridans.
Table 2. Sensitivity of qPCR versus culture in blood or CSF.
Samples Positive in qPCR
n (%)
Positive in culture Identified by qPCR only Identified by culture only
Blood
n = 143
128/143 (89.5%) 37/143 (25.9%) 91/143 (63.6%) 0/143
(0.0%)
OR 24.4;
95% CI 12.2–49.8;
p < .10−4 by χ2 test;
Cohen’s κ 0.08;
p<10−4 by McNemar’s test
CSF
n = 144
138/144
(95.8%)
46/144
(31.9%)
92/144 (63.9%) 1/144 (0.7%) OR 49.0;
95% CI 19.1–133.4;
p<10−4 by χ2 test;
Cohen’s κ 0.02;
p<10−4 by McNemar’s test
https://doi.org/10.1371/journal.pone.0212922.t002
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Positivity of blood culture did not correlate with higher bacterial loads. Actually, no differ-
ence in blood bacterial load was found between culture positive (37 samples, mean CT 27.7;
SD 5.71, median 28 range 16–36) and culture negative samples (91 samples, mean CT 28.1; SD
6.03, median CT 28.0; range 16–39, p = 0.739). As shown in Fig 1, a great overlap in bacterial
load values was found between culture positive and culture negative samples.
Bacterial load was not significantly different between patients who had received antibiotic
treatment or not (mean CT respectively 29.3±5.7 vs 27.7±5.1; p = 0.23) and it did not differed
among ages (S3A Fig).
The rate of culture positivity progressively decreased in parallel of treatment duration (S4A
Fig) and among the patients who were still positive in blood after >2 days of antibiotic treat-
ment there were patients with bacteremic meningococcal pneumonia and patients who died
after complicated courses.
Fig 1. Cycle threshold in patients with invasive meningococcal disease who were found positive by qPCR in blood and who were positive (blue) or negative (orange)
in blood culture. Cycle threshold is inversely proportional to bacterial load.
https://doi.org/10.1371/journal.pone.0212922.g001
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Correlation between bacterial load and positivity of CSF culture
In order to evaluate correlation between culture positivity in CSF and CSF bacterial loads, we
evaluated all samples that were positive by qPCR in CSF and in which culture tests had been
performed (n = 138). CSF culture was positive in 45/138 (32.6%), negative in 92/138 (66.7%)
and reported as contaminated in 1/138 (0.72%).
No difference was found between CSF CT in culture-positive or culture negative patients:
among the 45 patients whose CSF culture was positive, CT of qPCR ranged between 13 and 35
(mean = 23.1; median = 22.5, SD 4.9); of 93 samples that tested negative for Neisseria meningi-
tidis by CSF culture, CT ranged between 13 and 39 (mean = 24.7; median = 25, SD5.4);
p = 0.11. (Fig 2).
Bacterial loads were not different between patients who received antibiotic treatment before
hospital admission and patients who did not.
Fig 2. Cycle threshold in patients with invasive meningococcal disease who were found positive by qPCR in cerebrospinal fluid (CSF) and who were positive (blue)
or negative (orange) in CSF culture. Cycle threshold is inversely proportional to bacterial load.
https://doi.org/10.1371/journal.pone.0212922.g002
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Different from what was shown in blood culture, the positivity rate of CSF cultures did not
decrease in the first 2 days of antibiotic treatment (S4A Fig). However the number of patients
in whom lumbar puncture was performed after 2 or more days of treatment was too low to
allow stratification and statistical analysis of the results.
Differences in culture positivity among ages are shown in S3B Fig.
Correlation between fatal outcome and bacterial load or culture positivity
Blood. During the study period, a total of 41 deaths occurred among the 313 patients
affected by invasive meningococcal disease, resulting in a case-fatality rate of 13.1%.
In order to evaluate whether culture positivity was associated with more severe cases and
fatal outcome, we evaluated all culture results from deceased patients.
The proportion of positive blood cultures in patients who died (10 positive among 25 cul-
tures performed in patients who died; 40.0%) was higher compared to the proportion found in
patients who survived (32 positive among 163 cultures performed in patients who survived
19.6%, p = 0.036, OR 2.73; 95% CL 1.025–7.215), however 60% of deaths would have remained
undiagnosed with the use of culture only.
qPCR was able to predict fatal outcome: CT values in blood from patients who died were
significantly lower, identifying higher bacterial loads, compared with CT values of patients
who survived (respectively mean 18.0, median 18.0 range 14–23 versus mean 29.6, median 30
range 16–39; p<10−17) (Fig 3). None of the patients with CT>23 in blood had a fatal outcome.
Three out of four patients who survived despite a CT< 20 had been previously vaccinated.
Cerebrospinal fluid. Neither bacterial load nor CSF culture positivity correlated with
fatal outcome. Actually, in CSF no difference was found between CT found in patients who
died and CT found in patients who survived (respectively mean 24.3, range 14–35 versus mean
24.7, range 13–39, p = 0.816) (Fig 4).
As for cultures, no difference in the proportion of positive CSF cultures was found between
patients who died (3/11 available cultures; 27.3%) and patients who survived (42/136 available
cultures; 30.9%; p = 1.0 by Fisher test, OR 0.839, 95% CI 0.167–3.731).
Overall in 41 patients who died, blood cultures were obtained in 25 and were positive in 10/
25, while CSF cultures were obtained in 11 patients and were positive in 3/11. Altogether
among 41 patients who died 32 had at least one culture test performed and in 11/32 (34.4%)
cultures identified an IMD; diagnoses was obtained by PCR only in 65.6% of patients who
died. The proportion of patients that were identified by PCR only did not differ between
patients who died (21/32, 65.6%) and patients who survived (121/184, 65.8%; p = 0.99, OR
1.006, 95% CI 0.423–2.361).
Discussion
Several factors are known to be associated with IMD outcome: among these meningococcal
serotypes and bacterial load (measured with qPCR) or host-related factors such as IL-1 and IL-
1RN polymorphisms [14].
It has been previously demonstrated in different countries and setting in the world, that at
least half of IMD diagnoses are missed if only culture is used for diagnosis [3,5,7,19]. However,
until now, it had still been unclear whether culture might be able to identify all or at least the
majority of most severe cases, whether culture positivity might be associated with higher bacte-
rial loads and, therefore, might predict a more serious outcome of IMD.
Real-time PCR is a quantitative or semi-quantitative test and it has been previously demon-
strated that bacterial load is inversely related to CT[10,14].
Real-time Polymerase Chain Reaction and culture in the diagnosis of invasive meningococcal disease
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Our study, performed on a large group of IMD cases obtained from the national register for
molecular surveillance of bacterial disease in Italy, confirmed [15] that the bacterial load was
significantly higher in the blood of patients who died compared to patients who survived.
Actually, low CT levels in blood strongly correlated with fatal outcome and no death was
recorded in patients with CT over 23, with a positive predictive value for death of about 60%
for CTs <23 and negative predictive value of 100% for CTs over that level. As for culture, our
study showed that the proportion of culture-positive results is higher in patients who died
compared to patients who survived IMD (40% vs 20%), but still, 60% of deaths would have
remained undiagnosed with the use of culture only.
Fig 3. Cycle threshold in blood of patients with invasive meningococcal disease who died (blue) or survived the disease (orange). Cycle threshold is inversely
proportional to bacterial load.
https://doi.org/10.1371/journal.pone.0212922.g003
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As for CSF, neither a higher bacterial load nor CSF culture positivity was significantly asso-
ciated with death. That was not unexpected since it is well known that, in both IMD and pneu-
mococcal infections, lethality is strictly associated with the presence of sepsis more than with
meningitis [15, 20].
In the clinical field, qPCR is a pivotal tool not only for IMD diagnosis and serotyping but
also for disease prognosis. As for diagnosis, qPCR was over 3 times more sensitive than culture
in diagnosis of IMD. Furthermore, it decreases the time of identification of N. meningitidis,
thus improving case ascertainment by confirmation of infections and allowing both the best
therapy for the patient and prophylaxis for contacts to be initiated. Besides that, qPCR allows
serogroup determination in culture negative, clinically suspected IMD and that is important
for outbreak individuation, for epidemiological surveillance of IMD [21] and for vaccination
Fig 4. Cycle threshold in cerebrospinal fluid (CSF) of patients with invasive meningococcal disease who died (blue) or survived the disease (orange). Cycle
threshold is inversely proportional to bacterial load.
https://doi.org/10.1371/journal.pone.0212922.g004
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planning. The thought that culture methods misses a limited number of cases and especially
the less severe or atypical ones may have driven the decision not to implement molecular
methods in clinical microbiology laboratories. Our study confirms that in the absence of qPCR
2/3 of etiologic diagnoses of IMD are missed and suggests, for the first time, that even among
the most severe and fatal cases, 60% would remain undiagnosed. Therefore qPCR confirms to
be a paramount tool in IMD surveillance. Therefore, to add qPCR to other microbiological
tests as a mandatory test, would significantly improve the understanding of the disease.
Moreover a confirmed diagnosis of meningococcal infection allows antibiotic treatment
spectrum and duration to be limited. In contrast, treatment to cover suspected bacterial men-
ingitis or other invasive infections where no pathogen is identified is often much longer, with a
broader range of agents used.
On the other hand, even though antibiotic resistance is not currently a problem in menin-
gococcal infections, at present culture testing should always be performed in patients with
meningitis or sepsis since it remains the most important method in acquiring information
about antibiotic resistance in infections caused by to other pathogens.
It is well known [21–22] that low sensitivity of cultures is associated with antibiotic treat-
ment started before microbiological tests; however, other factors undoubtedly interfere with
the lack of sensitivity.
Actually, in the present study, most patients were admitted to the hospital without any pre-
vious antibiotic treatment and microbiological tests were performed before treatment was
started. Furthermore, patients with positive or negative culture tests did not differ in the use of
antibiotics or treatment (length of treatment and number of doses). Moreover, bacterial loads
were not different between patients who received antibiotic treatment before hospital admis-
sion and patients who did not, as previously demonstrated in CSF [20]. Therefore, other fac-
tors, such as transport conditions or sample volume, should also be considered as important
interfering factors.
An association between culture positivity and case-fatality rate has been recently found by
other researchers, even though limited to pediatric cases [3]. It has been hypothesized [3] that
culture positivity may be dependent on an uncontrolled bacterial replication (and conse-
quently a higher bacterial load) or on the fact that strains found in culture may be more viru-
lent. Our data suggest that is not the case in Italy where blood bacterial loads and severe
outcome are strictly associated, while the association with blood culture positivity was poor.
Since a correlation between bacterial loads and culture positivity was found in CSF and not in
blood, it is difficult to imagine that strain-dependent factors are determinants of culture-
positivity.
The present study has a potential bias since it was started as a pediatric study and adult
patients were included in the study upon clinician request; therefore age distribution does not
exactly reflect IMD age distribution in Italy, with a percentage of cases over 15 of 48% instead
of an expected rate of 55%. However since no difference was found in the present study
between pediatric or adult cases in term of PCR sensitivity or other study aims, it is unlikely
that the lower number of adults studied may influence the study findings.
Another potential bias is that while the qPCR assays were done in a single laboratory under
stringent quality control procedures, blood culture results came from the many different hos-
pitals where the study patients were seen and no information is available about the procedure
used. However no difference in culture positivity rates were found in the present study among
different Italian regions so that it seems unlikely that differences among procedures may have
influenced the overall results.
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Conclusions
In conclusion our study demonstrated that qPCR is significantly (at least 3 times) more sensi-
tive than culture in the laboratory confirmation of IMD. We also demonstrated that culture
negativity is not associated with lower bacterial loads and with less severe cases. Actually, even
among the group of patients who died about 60% of patients would not have had laboratory
confirmation without the use of qPCR. Bacterial load, evaluated by qPCR, appears strictly asso-
ciated with disease outcome, since higher bacterial load were strongly associated with most
severe cases and fatal outcome. Moreover our study highlighted the importance of PCR testing
in confirming the diagnosis of IMD and in identifying meningococcal serotype even in cul-
ture-negative samples. Therefore, in settings with high rates of culture-negative results [5,23],
molecular techniques such as qPCR can provide a valuable addition to the proportion of diag-
nosed cases of IMD.
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